Elanco Animal Health Inc (ELAN) concluded trading on Wednesday at a closing price of $14.72, with 4.67 million shares of worth about $68.7 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 22.06% during that period and on July 02, 2025 the price saw a gain of about 2.01%. Currently the company’s common shares owned by public are about 496.46M shares, out of which, 491.95M shares are available for trading.
Stock saw a price change of 6.98% in past 5 days and over the past one month there was a price change of 9.69%. Year-to-date (YTD), ELAN shares are showing a performance of 2.01% which increased to 21.55% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $8.02 but also hit the highest price of $15.78 during that period. The average intraday trading volume for Elanco Animal Health Inc shares is 6.32 million. The stock is currently trading 5.80% above its 20-day simple moving average (SMA20), while that difference is up 17.22% for SMA50 and it goes to 20.57% higher than SMA200.
Elanco Animal Health Inc (NYSE: ELAN) currently have 496.46M outstanding shares and institutions hold larger chunk of about 100.89% of that.
The stock has a current market capitalization of $7.31B and its 3Y-monthly beta is at 1.67. PE ratio of stock for trailing 12 months is 19.65, while it has posted earnings per share of $0.75 in the same period. Its PEG reads 3.22 and has Quick Ratio of 1.46 while making debt-to-equity ratio of 0.69. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ELAN, volatility over the week remained 2.86% while standing at 2.90% over the month.
Analysts are in expectations that Elanco Animal Health Inc (ELAN) stock would likely to be making an EPS of 0.2 in the current quarter, while forecast for next quarter EPS is 0.13 and it is 0.96 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.18 which is 0.22 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 0.3 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -7.58% while it is estimated to increase by 13.21% in next year. EPS is likely to shrink at an annualized rate of 6.11% for next 5-years, compared to annual growth of 29.95% made by the stock over the past 5-years.
Coverage by UBS stated Elanco Animal Health Inc (ELAN) stock as a Buy in their note to investors on December 09, 2024, suggesting a price target of $18 for the stock. On December 02, 2024, Leerink Partners Initiated their recommendations, while on September 19, 2024, Morgan Stanley Downgrade their ratings for the stock with a price target of $15. Stock get a Buy rating from Stifel on January 05, 2024.
